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Abstract
Over 4 million infants die each year from infections, many of which are vaccine-preventable. Young infants respond
relatively poorly to many infections and vaccines, but the basis of reduced immunity in infants is ill defined. We sought to
investigate whether myeloid-derived suppressor cells (MDSC) represent one potential impediment to protective immunity
in early life, which may help inform strategies for effective vaccination prior to pathogen exposure. We enrolled healthy
neonates and children in the first 2 years of life along with healthy adult controls to examine the frequency and function of
MDSC, a cell population able to potently suppress T cell responses. We found that MDSC, which are rarely seen in healthy
adults, are present in high numbers in neonates and their frequency rapidly decreases during the first months of life. We
determined that these neonatal MDSC are of granulocytic origin (G-MDSC), and suppress both CD4+ and CD8+ T cell
proliferative responses in a contact-dependent manner and gamma interferon production. Understanding the role G-MDSC
play in infant immunity could improve vaccine responsiveness in newborns and reduce mortality due to early-life infections.
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Introduction
Despite progress in reducing the infant mortality rates over the
last two decades, infectious disease remains a major cause of infant
mortality, with an estimated 4.9 million deaths per annum [1]. A
major goal of neonatal vaccinology is the induction of protective
immunity before the age at which most infections occur.
Development of vaccines that can induce protective immunity at
this vulnerable age has been hampered in part by differences in T
cell responses during infancy [2–5]. The neonatal immune system
is biased to tolerogenic and Th2 type responses, compared to older
children and adults [6]. We hypothesized that one reason for
altered T cell responses in early life may be active suppression by
myeloid-derived suppressor cells (MDSC), a heterogeneous
population of activated myeloid cells with suppressive function
[7–9] [10]. While a tolerant, anti-inflammatory state is likely
advantageous for full-term viviparity [11–13], its persistence after
birth may contribute to the reduced ability of infants to respond to
infections and vaccinations in early life.
In certain pathologies, in particular cancer and persistent
inflammatory conditions, an accumulation and activation of
granulocytic or monocytic MDSC that express suppressive factors
such as Arginase-1, reactive oxygen species, and inducible nitric
oxide synthase [7–9] has been observed. The vast majority of
research on MDSC to date has focused on populations of MDSC
induced in murine cancer models and in humans with malignancy
[7–9]. Recently, high frequencies of granulocytic (G)-MDSC were
described in cord blood [14]. In this study, we confirm these
findings and further characterize the frequency and immunosup-
pressive function of this G-MDSC population.
G-MDSC express cell markers similar to neutrophils and
recently, mature neutrophils have been found to be either
inflammatory (N1) or immunosuppressive (N2) [15–17]. The
relationship between the mature immunosuppressive neutrophils
and G-MDSC has not been established, however murine
transcriptomic analysis has revealed significant differences be-
tween G-MDSC and suppressive mature neutrophils [18]. We
therefore also examined the nuclear morphology and heterogene-
ity of the population of G-MDSC further differentiating them
from mature neutrophils.
Materials and Methods
Sample collection and processing
Adult blood samples were collected from healthy volunteers at
the Seattle Biomedical Research Institute. Cord blood from
PLOS ONE | www.plosone.org 1 September 2014 | Volume 9 | Issue 9 | e107816
healthy, full-term Caesarean section deliveries was collected at the
Valley Medical Center, Department of Obstetrics and Gynecol-
ogy, University of Washington (UW). Blood from healthy 6-week
old babies was collected during study visits at the Khayelitsha Day
Hospital, Provincial Administration of the Western Cape,
University of Cape Town. Blood from 6–24 month-old healthy
infants was collected during elective surgeries at Seattle Children’s
or UW. The Institutional Review Boards from Seattle Biomedical
Research Institute, UW, Valley Medical Center and University of
Cape Town approved the studies and all adult individuals
provided written informed consent and guardians provided proxy
consent for infants.
Cord blood mononuclear cells (CBMC), infant, or adult PBMC
were isolated over Ficoll-Hypaque gradients. CBMC were further
depleted of red blood cells by glycophorin A negative selection
(Miltenyii Biotech). All assays were performed within 8 hours of
collection of cord blood or peripheral blood since G-MDSC do
not survive cryopreservation (data not shown and [19]).
Phenotypic analysis of G-MDSC populations and flow
cytometry
Antibodies against the following surface antigens were used to
identify G-MDSC populations: HLA-DR (L243), CD14 (M5E2),
CD11b (ICRF44), CD33 (WM53), purchased from BD Biosci-
ences, and CD15 (HI98, BioLegend). Intracellular staining was
detected after permeabilization and staining with previously
labeled Alexa Flour 488 (Invitrogen) anti-arginase-1 antibody
(clone 6G3; Hycult Biotechnologies). Viable cells were identified
by staining with Live Dead Amine (Invitrogen). All stained samples
were fixed in 1% paraformaldehyde and acquired using an LSRII
Flow cytometer (BD). Data were analyzed using FlowJo software
(Tree Star).
Neutrophil, G-MDSC and T cell enrichment
G-MDSC and T cells were isolated from the CBMC interface of
a Ficoll gradient by CD15 (Miltenyii Biotech) or CD3 (EasySep)
positive magnetic bead selection, respectively. For the isolation of
naı̈ve adult T cells, T cells were enriched by negative selection
(EasySep) followed by depletion of memory T cells using
CD45RO magnetic beads (Miltenii Biotech). Neutrophils were
isolated from the red blood cell (RBC) pellet of a Ficoll gradient by
Ammonium Chloride RBC lysis (EasySep) followed by neutrophil
enrichment (EasySep). Purity of the positively and negatively
selected subsets was greater than 95%.
Wright-Giemsa Stain
Purified neutrophils and G-MDSC were processed for cytospin
and Wright-Giemsa stains and analyzed at the Clinical Pathology
Laboratory at Seattle Children’s Hospital.
T cell suppression assay
Effector CBMC or CD3pos T cells were CFSE-labeled
(Molecular Probes) and cultured at 26106 cells/ml. T cells were
stimulated with anti-CD3/CD28 coated beads (BD) in RPMI plus
15% human sera with the daily addition of 0.1 ng/mL rhuIL-7
(R&D Systems). CD15pos MDSC were depleted from CBMC or
added to purified T cell cultures at a 1:1 effector-to-suppressor
ratio. Negative controls included effector cells with or without
suppressor cells, without anti-CD3/CD28 stimulation. On day 5,
cells were permeabilized, stained with anti-CD3 (UCHT1 or
SK7), CD4 (RPA-T4), CD8 (SK1) from BD Biosciences and
proliferation of T cells was assessed by analysis of lymphoid-gated,
CD3pos, CFSElo cell populations. Positive proliferative responses
were calculated after subtraction of background proliferation from
corresponding negative control wells. Percent suppression was
calculated by the following formula: %CFSElo (CBMC) -
%CFSElo (CBMC-CD15)/%CFSElo (CBMC-CD15) 6100.
IFN-gamma ELISpot analysis
Effector CBMC or CD15-depleted CBMC were plated at
100,000–200,000 PBMC or 20,000 purified CD3pos T cells per
well in IFN-c ELISPOT assays (Millipore), as previously described
[20,21] with the addition of IL-12 (10 ng/mL) and IL-7 (1 ng/
mL, R&D Systems) for the neonatal T cells. The number of spot
forming cells (SFC) was calculated by subtracting the mean
number of spots in the negative control wells from the mean
number of spots for each stimulation condition. An IFN-c result
was considered positive when the background-subtracted number
of SFC was twice the background (negative control) and at least 50
SFC per million CBMC or T cells.
Statistical analysis
For statistical analysis of G-MDSC frequency comparisons by age
group and T cell proliferative responses in the presence or absence
of G-MDSC, Mann-Whitney and the Wilcoxon Matched-Pair
Signed Rank tests were used, respectively. The correlation between
G-MDSC frequencies and suppression of T cell proliferation by G-
MDSC was measured using the Spearman rank correlation test.
Non-parametric tests were two-tailed, with a P value of less than
0.05 considered statistically significant. All statistical analyses and
graphing were conducted using GraphPad Prism 5.0 d (GraphPad).
Results
G-MDSC are present at high frequency at birth and
gradually decline with postnatal age
To establish the prevalence of MDSC during early life, MDSC
frequencies were analyzed by flow cytometry in blood mononu-
clear cells isolated from healthy (i) cord blood (CB); (ii) 6-week-old
infants; (iii) 6–24 month-old infants; and (iv) adults. Frequencies of
both monocytic MDSC (M-MDSC; defined as HLA-DRneg,
CD14pos, CD33pos, CD11bpos) and G-MDSC (defined as HLA-
DRneg CD14neg, CD33pos, CD11bpos, and CD15pos) were
quantified (Fig.1A and Fig. S1 for fluorescence minus one
(FMO) controls). The frequencies of M-MDSC were below 1%
of live cells, did not differ significantly between cord blood and
adult peripheral blood, and were, therefore, not analyzed further.
We identified a prominent population of G-MDSC in CB that
decreased with age and were generally absent in healthy adults
(median frequencies: 5.8% in CB; 4% at 6-weeks of age; 1.2%
between 6–24 months and 0.8% in adults, Fig.1B). Over 90% of
these cells were positive for Arginase-1 (Fig.1A), confirming their
granulocytic nature [22–25]. Interestingly, G-MDSC frequencies
observed in CB were typical of those reported in peripheral blood
of cancer patients [23–25]. CB G-MDSC were further character-
ized by Wright Giemsa stain, which showed heterogeneous
populations of hypodense-immature and mature neutrophils (47–
69% neutrophils; 7–16% bands; 11–25% metamyelocytes and 6–
8% myelocytes, based on 2 experiments; Fig.1C,D) further
confirming these as G-MDSC.
Isolated neonatal T cells have more variable proliferative
responses compared to adult naı̈ve T cells in response to
polyclonal stimulation
Neonatal T cell responses to infection and vaccines are reduced
compared to adults with a delay in the acquisition of antigen-
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specific CD4pos T cell responses as well as decreased cytokine
responses [6]. We therefore sought to assess if neonatal T cells
have a decreased ability to proliferate in response to polyclonal
stimulation when isolated from the rest of cord blood peripheral
mononuclear cells (CBMC). To assess this, T cells were purified
using magnetic beads and stimulated with anti-CD3/anti-CD28
beads. Adult T cells were further enriched for naı̈ve T cells
(CD45ROneg). The proliferative capacity of T cells was measured
by CFSE dilution five days after stimulation (Fig. 2A). As shown in
Fig. 2B, neonatal T cells show highly variable proliferative
capacity compared to naı̈ve adult T cells, with a lower median
proliferation (p = 0.008).
Neonatal G-MDSC further inhibit T cell proliferative
responses in vitro in a contact-dependent manner
In cancer patients, increased G-MDSC frequencies have been
recognized as potent inhibitors of T cell responses, limiting the
effectiveness of immunotherapy [23–25]. In order to assess
whether infant G-MDSC behave similarly, T cells and G-MDSC
were purified from CBMC using anti-CD3 or anti-CD15 magnetic
beads, respectively. CFSE-labeled CB-derived CD3pos T cells were
stimulated with anti-CD3/anti-CD28 beads with or without G-
MDSC (Fig. 2A). Addition of G-MDSC resulted in significantly
reduced proliferative capacity of neonatal T cells (Fig. 2A; p,
0.001). This reduction in proliferative capacity induced by G-
MDSC occurred in both CD4pos and CD8pos T cells (Fig. 2A).
Furthermore, the suppressive effects of G-MDSC on neonatal T
cell proliferation showed a dose response (Fig. 2C). Finally, in
order to assess if the effect of G-MDSC is contact dependent, T
cells and G-MDSC were separated by a 0.45 um transwell
(Fig. 2D). Separating G-MDSC from T cells with the transwell
eliminated the suppressive ability of G-MDSC, indicating that
their effect is entirely contact dependent.
The frequency of neonatal G-MDSC correlates with the
proliferative capacity of CBMC after polyclonal
stimulation
To analyze the effect of G-MDSC on the capacity of T cells in
whole CBMC (rather than isolated T cells) to proliferate after
Figure 1. Characterization and longitudinal analysis of MDSC populations in cord blood, infants and adults. (A) Gating strategy and
identification of HLA-DR/CD14neg, CD33/CD11b/CD15pos G-MDSC in adult and cord blood. Further characterization of HLA-DR/CD14neg, CD33/CD11b/
CD15pos cells by intracellular staining of Arginase I. (B) Frequency of HLA-DR/CD14neg, CD33/CD11b/CD15pos cells of: (i) CBMC isolated from CB
collected from healthy pregnancies in Seattle, WA (n = 25); (ii) PBMC isolated from neonates in Cape Town, South Africa at 6-weeks of age (n = 9); (iii)
PBMC isolated from 6–24 month-old infants in Seattle, WA (n = 29); (iv) and PBMC isolated from healthy adults in Seattle, WA (n = 28). Statistical
significance determined by the Mann Whitney test. (C) Wright-Giemsa cytospin of CB samples and phenotype determination by clinical pathology of
neutrophils and G-MDSC (Average, n = 2 independent experiments). Magnification 600X. (D) Proportions of neutrophils at various stages of
development in the neutrophil and the G-MDSC fractions.
doi:10.1371/journal.pone.0107816.g001
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polyclonal stimulation, G-MDSC were depleted by CD15 bead
isolation from CBMC. CFSE-labeled CBMC or CD15-depleted
CBMC were stimulated with anti-CD3/anti-CD28 beads. As
shown in Fig. 2E, the amount of T cell suppression directly and
significantly correlated with the frequency of G-MDSC in CB
(r = 0.73, p = 0.002).
Neonatal T cells produce lower amounts of IFN-gamma
compared to naı̈ve adult T cells, this is further suppressed
by neonatal G-MDSC
In order to assess if neonatal T cells are also defective at
producing IFN-gamma, CD3pos cells from CB were stimulated
with anti-CD3/anti-CD28 beads and compared to naı̈ve CD3pos
T cells from adults. As shown in Fig 3A, neonatal T cells have a
lower median IFN-gamma secretion though it did not reach
significance (p = 0.081).
We sought to assess if neonatal G-MDSC also affect IFN-
gamma secretion after polyclonal stimulation since IFN-gamma
production is decreased by MDSC in cancer patients [26]. G-
MDSC were depleted from whole CBMC by anti-CD15 bead
isolation and IFN-gamma responses were compared to non-
depleted CBMC by ELISpot after anti-CD3/anti-CD28 stimula-
tion. As shown in Fig. 3B, depletion of G-MDSC significantly
increased IFN-gamma production (p = 0.017). However, unlike
with the proliferative assays, the frequency of G-MDSC in CB did
not correlate with the ability of G-MDSC to suppress IFN-gamma
production Fig. 3C, r = 0.23, p = 0.485).
Figure 2. Effect of neonatal G-MDSC on T cell proliferation. (A) Proliferative responses of purified T cells in the presence or absence of G-
MDSC after anti-CD3/CD28 bead stimulation (n = 28 independent experiments performed in duplicate for CD3 plots, n = 6 for CD4 and CD8 plots).
Significance determined by the Wilcoxon Matched-Pair Signed Rank test. (B) Proliferative responses of purified adult naı̈ve T cells (n = 9 independent
experiments performed in duplicate) compared to cord blood T cells (n = 28 independent experiments performed in duplicate) after anti-CD3/CD28
bead stimulation. Statistical significance determined by the Mann Whitney test. (C) Suppression of T cell proliferation by autologous G-MDSC
titration. (n = 4 independent experiments performed in duplicate). (D) Suppression of T cell proliferative responses by G-MDSC is contact dependent.
(n = 5 independent experiments performed in duplicate). (E) G-MDSC frequency correlates with suppression of T cell proliferation by G-MDSC. G-
MDSC frequencies were correlated to suppression of T cell proliferation by G-MDSC using the Spearman rank correlation test (n = 16 independent
experiments).
doi:10.1371/journal.pone.0107816.g002
Figure 3. Effect of G-MDSC on IFN-gamma production. (A) Cord blood CD3pos T cells and adult CD3pos CD45ROneg T cells were assessed for
IFN-gamma production by ELISpot after anti-CD3/CD28 bead stimulation (n = 11 independent experiments performed in triplicate for neonates and 9
independent experiments for adults). Statistical significance determined by the Mann Whitney test. (B) Neonatal G-MDSC decrease IFN-gamma
production after anti-CD3/CD28 bead stimulation. (n = 13 independent experiments performed in triplicate). (C) G-MDSC frequency correlation with
suppression T cell of IFN-gamma production by G-MDSC. G-MDSC frequencies were correlated to suppression using the Spearman rank correlation
test (n = 11 independent experiments).
doi:10.1371/journal.pone.0107816.g003
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Discussion
Little is known about what governs the immunologic differences
seen in early life, or how these change over time. An immune-
suppressive feto-maternal environment appears necessary for
healthy full-term gestation, as inflammation has been shown to
be associated with pre-term parturition and fetal injury [27].
Several maternal immune-suppressive mechanisms have already
been identified, including regulatory T cells, regulatory NK cells,
and regulatory molecule expression such as galectin-1, PDL1, and
Tim3 [12,28–34], and failure of some of these mechanisms is
associated with spontaneous abortion. Active suppression of fetal
immune responses in utero is also likely necessary because a
bidirectional transfer of nucleated cells occurs across the placental
barrier and these could initiate an anti-maternal response [35,36].
A high proportion of regulatory T cells have been described in the
fetus, which decrease during gestation and reach adult-levels by
term gestation [35,37]. A second suppressive cell of erythroid
origin has recently been identified in CB [38]. Here we have
described another population of suppressive cells in early life: a
high proportion of G-MDSC in CB of healthy neonates that
gradually declines in frequency during the first 6 months of life.
The data presented in this study corroborate and broaden the
findings of Rieber et al. [14]. We have confirmed G-MDSC, but
not M-MDSC, are present at elevated frequencies in CB and
further characterized these frequencies in the first 2 years of life.
To this end we demonstrated that by 6 weeks of age, median G-
MDSC frequencies decreased by 30% and that median G-MDSC
frequencies did not reach adult levels until after 6 months of age.
We also confirmed the findings of Rieber et al. demonstrating that
neonatal G-MDSC suppress CD4pos and CD8pos proliferative and
IFN-gamma production responses. While Rieber et al. found that
the effect of MDSCs on T or NK cells was partially contact
dependent, we found that suppression of T cell proliferative
responses by G-MDSC was completely contact dependent [14].
Furthermore, we demonstrated that in the presence of physiolog-
ical levels of G-MDSC there is a direct and significant correlation
between the G-MDSC frequency and the degree of suppression of
proliferative responses observed. Lastly, we have characterized the
nuclear morphology and composition of this G-MDSC population
in neonates compared to mature neutrophils and have demon-
strated that G-MDSC isolated from CB contain a heterogeneous
mixture of both hypodense mature and immature neutrophils.
Consistent with previous reports [6], we have demonstrated that
T cells in neonates are less responsive compared to naı̈ve T cell
responses from adults. Isolated neonatal T cells have a lower
proliferative capacity and secrete lower amounts of IFN-gamma
after polyclonal stimulation in vitro. In vivo, the ability of neonatal
T cells to mount effective responses is likely influenced by the
lower expression of B7 family molecules on antigen-presenting
cells (APCs) [39] and the defective cytokine production by these
cells [40]. T cell responses induced by several routine vaccines are
less polyfunctional, less proliferative and produce lower IFN-
gamma in infants compared to adults [41–47]. The combination
of lower capacity of T cells to proliferate and secrete IFN-gamma
combined with the increased frequencies of G-MDSC during the
first 6 months of life may impair the induction of protective
pathogen-specific and vaccine- induced T cell immune responses
in vivo. The age at which adult-like responses are achieved varies
according to vaccine type, but is generally attained between the
ages of 6 months to 1 year, which coincides with the age at which
we observe G-MDSC levels to decrease. However, additional
studies are required to determine whether this temporal associa-
tion indicates a causal relationship between G-MDSC frequency
and vaccine responsiveness in infants.
Neonatal G-MDSC have strong T cell suppressive activity in
vitro and their frequency in CB correlates with the proliferative
capacity of CB T cells in response to polyclonal stimulation in
vitro. Although the role these cells may play in vivo has not yet
been defined, MDSC have been implicated in skewing T helper
responses towards Th-2 phenotype, impairing NK responses, and
inhibiting dendritic cell function [7–9], all of which are
characteristics described in the neonate’s immune dysfunction
[2,4,48]. In cancer models, G-MDSCs can be differentiated from
immunosuppressive to immunogenic TNF-alpha secreting neu-
trophils after intra-tumoral injection of attenuated Salmonella
vaccine [49], and therapeutic vaccination to cancer antigens is
restored after in vivo depletion of MDSC [50–56]. Furthermore,
in cancer patients, MDSCs can be induced to differentiate and T
cell function and vaccine responses have been restored by
administration of either Vitamin A or Vitamin D3 [22,57–59].
Vitamin A and Vitamin D supplementation has also been shown
to increase protection after vaccination [60,61]. This raises the
intriguing possibility that if MDSC indeed modulate early life
immunity, interventions targeting MDSC might be designed that
enhance vaccine responsiveness and reduce infectious mortality.
Supporting Information
Figure S1 Fluorescence minus one (FMO) control to
identify positivity gates for MDSC populations with the
following antibody combination: Live Dead Amine, HLA-
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